Wormy Facts

Wormy Facts

Globally, 497.9 million children in need of treatment were reported as treated in 2024, corresponding to an estimated global coverage of 56.4%.

Wormy Facts

Wormy Facts

In 2024, an estimated 255.8 million preschool-aged children were estimated to need preventive chemotherapy for STH in 24 countries or territories.

Wormy Facts

Wormy Facts

In 2024, 84 countries required preventive chemotherapy for STH, based on prevalence.

Wormy Facts

Wormy Facts

As of 2024, more than 883 million children require preventive chemotherapy for STH worldwide.

Wormy Facts

Wormy Facts

WHO defines STH as a public health problem when >2% of the at-risk population has infection of moderate or high intensity with one or more soil-transmitted helminths (roundworm, whipworm, or hookworm).

Our work focuses on three pillars:

  • Country Support

    We support and build the capacity of national STH programs to ensure effective and efficient delivery of interventions.

  • Partnerships & Advocacy

    We build consensus among a broad group of stakeholders and seek to minimize duplication of efforts in advancing STH interventions.

  • Technical Leadership

    We provide scientific leadership to advocate for evidence-based approaches for the control of intestinal worm infections.

Who We Are

Children Without Worms, a program of the Task Force for Global Health, that aims to accomplish the vision of a world free of intestinal worms, so that communities may thrive and develop to their full potential. Children Without Worms works closely with the World Health Organization, pharmaceutical donors, non governmental organizations, national implementing partners, and private-public coalitions. Children Without Worms’ strategy transitioned from one of drug donation, to country engagement, partnerships and advocacy, and technical leadership.

Our Vision

We envision a world in which all at-risk children are healthy and free of intestinal worms so they may thrive and develop to their full potential.

Our Mission

To enhance the health and development of communities by eliminating the morbidity associated with intestinal worm infections.

Our Purpose

We believe that a world free of the morbidity from intestinal worms is possible. By building on existing knowledge, goodwill, and generosity, we are committed to build the capacity of global health programs to reach this goal. The primary tenets of our strategy are fueled by integrity, serving as a catalyst for collaboration and collective action to participate in the strengthening of national soil-transmitted helminthiasis (STH) programs, and responsiveness and flexibility to the needs of the global STH program.

Our Impact

As a non-governmental organization with non-state official actor status, we work closely alongside other non-governmental organizations, funding agencies, governmental organizations, and the World Health Organization, among whom we are well recognized for our first-hand knowledge of the challenges faced in STH control.

We acknowledge the critical support of our core funding partners:

  • GSK
  •   Johnson & Johnson